PTC Therapeutics (PTCT) PT Raised to $82 at RBC Capital
Tweet
Share
E-mailGet Alerts PTCT Hot Sheet
Price: $71.97 -0.92%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams raised the price target on PTC Therapeutics (NASDAQ: PTCT) to $82.00 (from $70.00) while maintaining a Outperform rating.
You May Also Be Interested In
- PTC Therapeutics (PTCT) PT Raised to $109 at Wells Fargo
- Macquarie Upgrades Inventec Corp (2356:TT) to Neutral
- Asia Vital Components Co Ltd (3017:TT) PT Raised to NT$4,250 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
